✦ LIBER ✦

PSS28 COST-EFFECTIVENESS OF USTEKINUMAB VERSUS ETANERCEPT IN SEVERE PLAQUE PSORIASIS PATIENTS: A CANADIAN PERSPECTIVE

✍ Scribed by Brazier, N; Pan, F; Shear, N; Jivraj, F; Schenkel, B; Brown, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS10 COST PER RESPONDER OF USTEKINUMAB

✍ SR Feldman; M Augustin; S Martin; P Szapary; B Schenkel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PSS12 MODELING THE COST-EFFECTIVENESS OF

✍ S Verma; S Dharmarajan; Y Yang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PSS25 COST-EFFECTIVENESS OF ETANERCEPT A

✍ JP Ortonne; D Feneron; JP Daures; AL Ollivier; C Thiriet; F Maurel; C Le Pen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost Utility Analysis Based on a Head-to

✍ Feng Pan; Nicole C. Brazier; Neil H. Shear; Farah Jivraj; Brad Schenkel; Ruth Br 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

PSY30 Cost-Effectiveness of Ustekinumab

✍ Valencia-Mendoza, A.; Hernández-Garduño, A.; Puig, A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PSS10 A COST-EFFECTIVENESS ANALYSIS OF E

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB